Literature DB >> 17393299

Role of Fra-2 in breast cancer: influence on tumor cell invasion and motility.

Karin Milde-Langosch1, Stanislava Janke, Ines Wagner, Christine Schröder, Thomas Streichert, Ana-Maria Bamberger, Fritz Jänicke, Thomas Löning.   

Abstract

Fra-2 (Fos-related antigen 2) is a member of the Fos family of AP-1 transcription factors which is often up-regulated in mammary carcinomas. Previous results suggested that it might be involved in the regulation of breast cancer invasion and metastasis. In order to analyze the role of Fra-2 in breast cancer cells, it was silenced in the highly invasive MDA-MB231 cells using RNA interference. On the other hand, stable transfectants of the weakly invasive MCF7 cell line were established in order to analyze the effects of Fra-2 overexpression. In both approaches, cell proliferation was not or only weakly influenced by Fra-2. In contrast, the invasive potential of the cells was increased, and a weaker effect on motility was observed. By cDNA microarray analysis of the MCF7 transfectants followed by validation on a protein level, we identified several Fra-2 target genes which might be involved in cell invasion and migration, i.e., ALCAM and connexin 43. Additionally, mRNA expression levels of various genes which are associated with a more malignant behavior of the tumors in vivo were up- or downregulated, i.e., members of the MAGE family, S100P, TIMP2, IL24 etc. These results show that Fra-2 overexpression is associated with a more aggressive tumor phenotype and is probably involved in breast cancer progression in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393299     DOI: 10.1007/s10549-007-9559-y

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  25 in total

Review 1.  S100P: a novel therapeutic target for cancer.

Authors:  Thiruvengadam Arumugam; Craig D Logsdon
Journal:  Amino Acids       Date:  2010-05-28       Impact factor: 3.520

2.  Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.

Authors:  R L Babu; M Naveen Kumar; Rajeshwari H Patil; K S Devaraju; Govindarajan T Ramesh; S Chidananda Sharma
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

3.  Global comparative gene expression analysis of melanoma patient samples, derived cell lines and corresponding tumor xenografts.

Authors:  Yaguang Xi; Adam Riker; Lalita Shevde-Samant; Rajeev Samant; Christopher Morris; Elaine Gavin; Oystein Fodstad; Jingfang Ju
Journal:  Cancer Genomics Proteomics       Date:  2008 Jan-Feb       Impact factor: 4.069

4.  Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells.

Authors:  Sun Yang; Bobbye Misner; Rita Chiu; Frank L Meyskens
Journal:  Mol Carcinog       Date:  2008-07       Impact factor: 4.784

5.  Evaluation of potential regulatory function of breast cancer risk locus at 6q25.1.

Authors:  Yaqiong Sun; Chuanzhong Ye; Xingyi Guo; Wanqing Wen; Jirong Long; Yu-Tang Gao; Xiao Ou Shu; Wei Zheng; Qiuyin Cai
Journal:  Carcinogenesis       Date:  2015-12-08       Impact factor: 4.944

6.  The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expression.

Authors:  Efrat Shema; Itay Tirosh; Yael Aylon; Jing Huang; Chaoyang Ye; Neta Moskovits; Nina Raver-Shapira; Neri Minsky; Judith Pirngruber; Gabi Tarcic; Pavla Hublarova; Lilach Moyal; Mali Gana-Weisz; Yosef Shiloh; Yossef Yarden; Steven A Johnsen; Borivoj Vojtesek; Shelley L Berger; Moshe Oren
Journal:  Genes Dev       Date:  2008-10-01       Impact factor: 11.361

7.  The prognostic significance of Jun transcription factors in ovarian cancer.

Authors:  Kerstin Eckhoff; Roland Flurschütz; Fabian Trillsch; Sven Mahner; Fritz Jänicke; Karin Milde-Langosch
Journal:  J Cancer Res Clin Oncol       Date:  2013-08-13       Impact factor: 4.553

8.  Fra-2/AP-1 regulates melanoma cell metastasis by downregulating Fam212b.

Authors:  Guang-Liang Chen; Rui Li; Xiao-Xiang Chen; Juan Wang; Shan Cao; Rui Song; Ming-Chun Zhao; Li-Ming Li; Nicole Hannemmann; Georg Schett; Cheng Qian; Aline Bozec
Journal:  Cell Death Differ       Date:  2020-11-13       Impact factor: 15.828

9.  Molecular and genomic approach for understanding the gene-environment interaction between Nrf2 deficiency and carcinogenic nickel-induced DNA damage.

Authors:  Hye Lim Kim; Young Rok Seo
Journal:  Oncol Rep       Date:  2012-09-26       Impact factor: 3.906

10.  An integrated pipeline for the genome-wide analysis of transcription factor binding sites from ChIP-Seq.

Authors:  Eloi Mercier; Arnaud Droit; Leping Li; Gordon Robertson; Xuekui Zhang; Raphael Gottardo
Journal:  PLoS One       Date:  2011-02-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.